Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (621-630 of 666) with videos related to

Pageof 67
Sort By:
Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
Cardiovascular Diabetology|February 7, 2025
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline WorkshopKatharine Barnard-Kelly, Tadej Battelino, Frank C Brosius, et al.
Cardiovascular Diabetology|February 24, 2026
From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforceChristoph Wanner, Francesco Cosentino, Katharine Barnard-Kelly, et al.
Kidney International|July 13, 2020
Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatmentIan H de Boer, M Luiza Caramori, Juliana C N Chan, et al.
Lancet (London, England)|June 5, 2026
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)Brendon L Neuen, Hiddo J L Heerspink, Vlado Perkovic, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2015
CKD Prevalence Varies across the European General PopulationKatharina Brück, Vianda S Stel, Giovanni Gambaro, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 2, 2025
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEYGreco B Malijan, Rebecca J Sardell, Natalie Staplin, et al.
Seminars in Dialysis|August 28, 2009
The role of EUTox in uremic toxin researchRaymond Vanholder, Omar Abou-Deif, Angel Argiles, et al.
Journal of the American Society of Nephrology : JASN|December 4, 2021
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease ProgressionBrendon L Neuen, Hocine Tighiouart, Hiddo J L Heerspink, et al.
Pageof 67

Showing results (621-630 of 666) with videos related to

Sort By:
Pageof 67
Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
Cardiovascular Diabetology|February 7, 2025
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline WorkshopKatharine Barnard-Kelly, Tadej Battelino, Frank C Brosius, et al.
Cardiovascular Diabetology|February 24, 2026
From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforceChristoph Wanner, Francesco Cosentino, Katharine Barnard-Kelly, et al.
Kidney International|July 13, 2020
Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatmentIan H de Boer, M Luiza Caramori, Juliana C N Chan, et al.
Lancet (London, England)|June 5, 2026
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)Brendon L Neuen, Hiddo J L Heerspink, Vlado Perkovic, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2015
CKD Prevalence Varies across the European General PopulationKatharina Brück, Vianda S Stel, Giovanni Gambaro, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 2, 2025
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEYGreco B Malijan, Rebecca J Sardell, Natalie Staplin, et al.
Seminars in Dialysis|August 28, 2009
The role of EUTox in uremic toxin researchRaymond Vanholder, Omar Abou-Deif, Angel Argiles, et al.
Journal of the American Society of Nephrology : JASN|December 4, 2021
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease ProgressionBrendon L Neuen, Hocine Tighiouart, Hiddo J L Heerspink, et al.
Pageof 67